Smithfield Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$224K Hold
503
0.01% 327
2025
Q1
$243K Sell
503
-155
-24% -$74.9K 0.01% 305
2024
Q4
$264K Hold
658
0.01% 300
2024
Q3
$307K Hold
658
0.02% 282
2024
Q2
$307K Hold
658
0.02% 261
2024
Q1
$276K Sell
658
-36
-5% -$15.1K 0.01% 279
2023
Q4
$280K Sell
694
-126
-15% -$50.8K 0.02% 271
2023
Q3
$286K Hold
820
0.02% 248
2023
Q2
$288K Buy
820
+10
+1% +$3.51K 0.02% 257
2023
Q1
$258K Buy
810
+16
+2% +$5.1K 0.02% 264
2022
Q4
$229K Buy
794
+15
+2% +$4.33K 0.02% 270
2022
Q3
$225K Buy
779
+263
+51% +$76K 0.02% 257
2022
Q2
$147K Hold
516
0.01% 337
2022
Q1
$135K Sell
516
-18
-3% -$4.71K 0.01% 372
2021
Q4
$116K Hold
534
0.01% 419
2021
Q3
$98K Sell
534
-25
-4% -$4.59K 0.01% 442
2021
Q2
$112K Hold
559
0.01% 419
2021
Q1
$120K Hold
559
0.01% 406
2020
Q4
$132K Sell
559
-406
-42% -$95.9K 0.01% 387
2020
Q3
$263K Sell
965
-63
-6% -$17.2K 0.02% 244
2020
Q2
$299K Buy
1,028
+518
+102% +$151K 0.03% 216
2020
Q1
$122K Buy
510
+248
+95% +$59.3K 0.01% 306
2019
Q4
$58K Hold
262
0.01% 496
2019
Q3
$45K Sell
262
-40
-13% -$6.87K ﹤0.01% 542
2019
Q2
$55K Hold
302
0.01% 509
2019
Q1
$55K Hold
302
0.01% 487
2018
Q4
$50K Hold
302
0.01% 472
2018
Q3
$59K Sell
302
-34
-10% -$6.64K 0.01% 501
2018
Q2
$57K Sell
336
-796
-70% -$135K 0.01% 514
2018
Q1
$184K Hold
1,132
0.02% 292
2017
Q4
$170K Buy
1,132
+242
+27% +$36.3K 0.02% 322
2017
Q3
$135K Buy
+890
New +$135K 0.02% 347
2013
Q3
Sell
-102
Closed -$8K 772
2013
Q2
$8K Buy
+102
New +$8K ﹤0.01% 656